Functionalized nanoscale micelles improve drug delivery for cancer therapy in vitro and in vivo

Tuo Wei, Juan Liu, Huili Ma, Qiang Cheng, Yuanyu Huang, Jing Zhao, Shuaidong Huo, Xiangdong Xue, Zicai Liang, Xing Jie Liang*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

183 Citations (Scopus)

Abstract

Poor penetration of therapeutic drugs into tumors is a major challenge in anticancer therapy, especially in solid tumors, leading to reduced therapeutic efficacy in vivo. In the study, we used a new tumor-penetrating peptide, CRGDK, to conjugate onto the surface of doxorubicin encapsulated nanoscale micelles. The CRGDK peptide triggered specific binding to neuropilin-1, leading to enhanced cellular uptake and cytotoxicity in vitro and highly accumulation and penetration in the tumors in vivo.

Original languageEnglish
Pages (from-to)2528-2534
Number of pages7
JournalNano Letters
Volume13
Issue number6
DOIs
Publication statusPublished - 12 Jun 2013
Externally publishedYes

Keywords

  • Targeted drug delivery
  • doxorubicin
  • micelle
  • neuropilin-1
  • tumor-penetrating peptide

Fingerprint

Dive into the research topics of 'Functionalized nanoscale micelles improve drug delivery for cancer therapy in vitro and in vivo'. Together they form a unique fingerprint.

Cite this